Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Buy zone. BYOC
They carried the 40+million accumulated deficit over from the last company to own this ticker, it’s a huge tax write off for future and a positive for BYOC.
I’m begging for it to happen, why wouldn’t you want an amazing SS? We would be QB as well which attracts better investors.
They got 500k in covid relief money. I think the quarterly revs are a money game to qualify.
Business Efficacy will be the next acquisition I bet. They are all partnered up with EG Insight and Customer Centred Strategies. Makes sense to roll them under one umbrella.
Our Board believes that, among other reasons, the number of outstanding shares of our Common Stock and very low trading price of our Common Stock have contributed to a lack of investor interest in the Company from institutional and other investors and has made it difficult for the Company to attract new investors and conduct equity financings on attractive terms or at all. Our Board believes that it may be necessary and prudent for the Company to amend our Articles of Incorporation to effect the reverse stock split because it would reduce the number of outstanding shares of our Common Stock to a level more consistent with other public companies with a similar anticipated market capitalization. Additionally, a reverse stock split should have the effect of raising the minimum bid price of our Common Stock on the OTCQB market, which was $0. per share as of August , 2020. The Board believes it will be beneficial to the stockholders if our Common Stock is traded on a recognized stock exchange, either The Nasdaq Capital Market or NYSE American (an “Exchange”). In the future we hope to apply to list our Common Stock on an
5
Exchange as soon as we are eligible to do so following the consummation of the Reverse Stock Split, a future public capital raise and satisfaction of other listing requirements and conditions. The Nasdaq Capital Market for example has minimum bid price requirement for new applicants of $4.00 per share. However, a company may qualify under a closing price alternative of $3.00 or $2.00 if the company meets varying requirements. On August , 2020, the last reported bid price of our Common Stock as reported by the OTCQB was $ per share. Although the Board believes that the Reverse Stock Split will enable the Company to meet these minimum market price requirements, there is no assurance that we will establish and maintain a market price in excess of the required level following the Reverse Stock Split or that even if we do establish such market price that any application to an Exchange would be successful. The effect of the Reverse Stock Split, if any, upon the stock price for our Common Stock cannot be predicted, and the history of similar stock split combinations for companies like us is varied. We also cannot assure you that the stock price of our Common Stock after the Reverse Stock Split will rise in proportion to the reduction in the number of shares of Common Stock outstanding as a result of the Reverse Stock Split because, among other things, the stock price of our Common Stock may be based on our performance and other factors as well. If we are successful in listing our Common Stock on an Exchange, the Board believes that such a listing will positively impact our ability to raise additional equity capital. However, there is also no assurance that we would be able to raise additional equity capital in a public offering or otherwise. Further, we are not currently eligible to make such application to list on an Exchange and cannot guarantee that we will be eligible in the future, or if we are eligible, that we will make such application or that such application will be approved.
The Board also believes that the current market price of our Common Stock has a negative effect on the marketability of the existing shares, and that the Reverse Stock Split may make the Common Stock more attractive to a broader range of institutional and other investors, as the current market price of the Common Stock may affect its acceptability to certain institutional investors, professional investors, and other members of the investing public. Many institutional investors look on stocks that are trading at low prices as unduly speculative in nature and, as a result, avoid investing in such stocks. Additionally, a variety of policies and practices of brokerage firms discourage individual brokers within those firms from dealing in low-priced stocks in light of brokers’ commissions and time-consuming procedures that make the handling of low-priced stocks unattractive to brokers from an economic standpoint. Many brokerage firms are also reluctant to recommend low-priced stock to their customers and the analysts at many brokerage firms do not monitor the trading activity or otherwise provide coverage for low-priced stocks. The Board believes the Reverse Stock Split may help to alleviate some of these problems, but there is no guarantee of increased marketability of the existing shares.
An additional principal effect of the Reverse Stock Split will be the reduction in the number of shares of Common Stock issued and outstanding from 2,987,681,061 shares as of August 4, 2020 to a range of approximately 29,876,811 to 298,768,106 shares, depending on the Reverse Stock Split ratio selected by the Board. The Reverse Stock Split will affect all of our stockholders uniformly and will not affect any stockholder’s percentage ownership interest in the Company or proportionate voting power, except to the extent that the Reverse Stock Split results in any of our stockholders holding a fractional share of our Common Stock. The Common Stock issued pursuant to the Reverse Stock Split will remain fully paid and non-assessable. The Reverse Stock Split shall not affect any rights, privileges or obligations with respect to the shares of Common Stock existing prior to the Reverse Stock Split, nor does it increase or decrease the market capitalization of the Company. The reverse stock split may increase the number of our stockholders who own “odd lots” of less than 100 shares of our Common Stock. Brokerage commissions and other costs of transactions in odd lots are generally higher than the costs of transactions of more than 100 shares of Common Stock. The Reverse Stock Split is not intended as, and will not have the effect of, a “going private transaction” under Rule 13e-3 of the Exchange Act. We will continue to be subject to the periodic reporting requirements of the Exchange Act. Following the Effective Date, we do not anticipate that the Company’s financial condition, the percentage ownership of management or any aspect of the Company’s business would materially change as a result of the Reverse Stock Split.
The Reverse Stock Split will not affect the par value of the Common Stock. As a result, on the effective date of any Reverse Stock Split, the stated capital on our balance sheet attributable to the Common Stock will be reduced in proportion to the fraction by which the number of shares of Common Stock is reduced, and the additional paid-in capital account shall be credited with the amount by which the stated capital is reduced. The per share net income or loss and net book value of our Common Stock will be retroactively increased for each period because there will be fewer shares of our Common Stock outstanding.
6
On the effective date of any Reverse Stock Split, all outstanding options and warrants will be adjusted to reflect the Reverse Stock Split. The number of shares of Common Stock that the holders of outstanding options and warrants may purchase upon exercise of their options and warrants will decrease, and the exercise prices of such options and warrants will increase, in proportion to the fraction by which the number of shares of Common Stock underlying such options and warrants are reduced as a result of the Reverse Stock Split, resulting in the same aggregate price being required to be paid as would have been paid immediately preceding the Reverse Stock Split.
Although our authorized Common Stock will be reduced as a result of any Reverse Stock Split, the overall effect after the Common Stock Increase will be an increase in our authorized but not outstanding or reserved shares of Common Stock. These shares may be issued by our Board in its discretion. Any future issuances will have the effect of diluting the percentage of stock ownership and voting rights of the present holders of Common Stock.
No further stockholder approval is required to affect any Reverse Stock Split.
It’s a beautiful thing, looking forward to the RS. When the dust settles it will be a company with a great SS and growing revenue. Hopefully the 10Q shows a large reduction on the notes but we will see on that. BYOC
It’s going to be awkward when the RS happens and the price doesn’t drop cause BYOC has recurring growing revenues with an awesome SS and tons of shares on lock.
Hoping to see big reduction on the notes with a revenue increase.
As long as they continue to clean the balance sheet and grow in happy.
After the Q I’m sure some juicy 8ks will follow.
So uplist with parterships, clients, acquisitions, funding/investors to announce, RS and have a public offering. The OTC PPS doesn’t dictate what will happen post uplist.
Here’s DUOT 10q before announcing doing an RS with uplist to Nasdaq Capital Markets. Not that far from BYOC, could get there with a single acquisition. Lucosky Brookman did the uplist and public offering.
https://www.otcmarkets.com/filing/html?id=13743705&guid=T3-6U6WMikqZD3h
If BYOC shouldn’t have a market cap this low either. Uplist will do a world of good for PPS, the RS is welcome.
Revenue up, shareholder deficit way down, net loss way down and now we’re getting a better share structure. If there is a continuation of the last Q on this one then of course the RS is vey positive. BYOC
The 700M are blocked for trade. BYOC
Beauty chart set up with news coming. Should be a nice run.
It’s as good as done, let the PRs flow.
Lol what do you think the market cap should be for a company like this?
It’s an SaaS company with yr over yr growth, Nasdaq capital markets uses SaaS valuation multiples so I’m not too concerned.
Pre..... BYOC
That will come in an 8k first when it happens.
Lol no it wouldn’t. Come on man. BYOC
Anything special would be in an 8K but would expect updated revenues(hopefully higher), current debt structure (hopefully way lower).
$1000 is $1000 after the RS folks. We are sitting way undervalued with revenue growth confirmed later this year.
Imagine thinking the price will drop after RS with the revenues and clients they have, market cap should be 10-20x higher what makes you think bigger pockets aren’t waiting for uplist.
They certainly can uplist and have an offering price of whatever they want with investors lined up.
They have all but announced we’re going to Nasdaq capital markets with a perfect share structure at no detriment to shareholders with partnerships, clients that they can’t announce until uplist.
Think about it.
Well the filing says they anticipate making the minimum uplist requirement of $2.00-$3.00 per share and the max RS they will do is 100:1 so do the math. We will see what they have on the hopper.
Obviously yes. Dilution devalues your shares while RS changes nothing, only improves the stock. Folks want to give me their shares of a 20 mil market cap company for a 1 mil market cap price that’s fine I’ll buy.
Isn’t that the discover note that was down to 1 million in the March Q? Look at the volume since then.
Difference is revenue here, valuation remains the same, RS has nothing to do with share value, if anything BYOC is more valuable post RS. Better share structure same revenue and partners. The valuation is the valuation which is currently about a 20mil minimum.
Not potential, it’s happening come on. Need to for Nasdaq it’s just OTC traders are used to RS then getting the dilution run up, they have worked hard to clear the books, doesn’t look like the plan to me.
Why do you think the split ratio has anything to do with killing shareholders. Your investment dollar value doesn’t change regardless if it’s a 1:2 or 1:10000, I know they had institutional investors interested in buying post uplist so we will see if they take it to 50M market cap post uplist.
Value of shares pre RS, $1 value of shares post RS $1. Uplist to Nasdaq, contracts, partnerships, acquisitions that cant be announced until uplist is complete.
Dilutive debt being consolidated to traditional debt. Share cancelation?
5mil revenue in first year, acquisition that will bring 1 million more that we know of.
Anything else? Sounds like the RS is positive to me.
Your money is the same before and after the split. BYOC will get the the proper valuation post split and uplist. Lots to announce after the uplist.
Almost every single OTC that uplists to Nasdaq has a pre-uplist split.
There you go, I have heard rumblings in the past that institutional investors were interested but not until the share structure and uplist happen. We will see.
Have you ever been in a RS that uplists to Nasdaq?
It was pretty obvious that this was coming with the uplist. If they are done with dilution and revenues are going up then this is a positive move for the company.
Everyone realizes 5 mil market cap is a 5 mil market cap after rs right? If dilution is over and they uplist then what’s the big deal exactly?
Small, Standard issue with Nasdaq uplisting.
BYOC was a shell 2-3 yrs ago. The last 10k was the first one with a full yr of revenue 5mil.